IDH1 Mutations Are Associated with Favorable Outcomes in Prostate Cancer

Study limitation reported by the research below: “The IDH2-mutated subgroup (n=12) is too small to draw reliable conclusions; survival data reported applies specifically to IDH1 mutations.”